How many tablets are in a box of Dacomitinib?

Dacomitinib (Dacomitinib) is an oral kinase inhibitor available in tablets containing 45, 30 or 15 mg of Dacomitinib , the common specifications are 45mg*30 tablets, 30mg*30 tablets or 15mg*30 tablets, that is, there are 30 tablets in a box. It is a blue film-coated immediate-release tablet. Dacomitinib has been approved for the treatment of locally advanced or metastatic non-small cell lung cancer. The drug can be used in adults with cancer cells that have a specific mutation that causes tumors to grow faster.

Lung cancer is caused by the malignant growth of cells in the airways (bronchial tubes). It is also called bronchial lung cancer. Some patients with non-small cell lung cancer have an abnormal protein called epidermal growth factor receptor (EGFR) in their tumor tissue. Mutated receptors may lead to uncontrolled tumor growth. There are many different mutations, such as L858R or del19. Dacomitinib is designed to block the mutated receptor in these patients, thereby preventing further tumor growth.

The original drug of dacomitinib has been launched in China and has entered the scope of Class B medical insurance. The price of the common specification 15mg*30 tablets per box may be more than 1,000 yuan; the European version of dacomitiniboriginal drug sold overseas, the specification 45mg*30 tablets may be more than 20,000 yuan per box (the price may fluctuate due to exchange rates). Currently, there are cheaper generic drugs of dacomitinib sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 45mg*30 tablets produced by a Lao pharmaceutical factory may be around a few hundred yuan per box (the price may fluctuate due to exchange rate effects).